期刊文献+

VEGF受体flk-1的表达与喉粘膜上皮癌变发生和转移的关系 被引量:6

Relationship between Expression of Vascular Endothelial Growth Factor Receptor, flk-1 and the Carcinogenesis and Metastases of Laryngeal Mucosa
暂未订购
导出
摘要 目的:观察血管内皮生长因子(VEGF)受体flk-1在不典型增生及鳞癌中的表达,用图象分析系统定量的方法观察flk-1与喉癌的生长、浸润及转移的关系。方法:用抗flk-1抗体,在经过微波处理组织暴露抗原后,进行标准化的EliteABC染色,并通过图象分析系统确定flk-1在不典型增生、鳞癌中的表达。结果:在不典型增生及鳞癌中flk-1均有表达。在组织中,flk-1不仅在血管内皮细胞中、在部分浆细胞和巨噬细胞中也呈阳性反应。鳞癌组中的flk-1的表达明显高于不典型增生组(P<0.05)。在鳞癌中,随着分化程度的下降,flk-1表达有逐渐递增的趋势。在鳞癌组中发生转移的病变flk-1的表达明显高于未转移组(P<0.05)。相关分析显示flk-1的表达与肿瘤的临床分期密切相关。结论:VEGF通过自分泌和旁分泌的途径影响肿瘤细胞生长及间质中新生血管的形成,肿瘤细胞的生长与血管的发生相互依赖。flk-1与喉癌的生长、浸润及转移密切相关,flk-1可能作为一个判断预后的重要指标。 Using automated image analysis to quantify the immunoreactivities of flk-1 in dysplasia (DYS) and malignant epithelia (SCC) of laryngeal mucosa, to observe the distributton of flk-1 and the relationship between flk-1 and the growth, infiltration andmetastases of laryngeal carcinoma. Results showed that flk-1 was expressed by the epithelial cell in all observed groups. The endothelial cells and the chronic inflammatorycells were also flk-1-positive stained. The expression of flk-1 was higher in SCC than inDYS. The expression of flk-l in metastatic SCC was significantly higher than in theSCC without metastases. Correlation analysis indicated that expression of flk-l washighly correlated with the clinical stage. We concluded that VEGF could influence thegrowth of both tumour cells and newly foumed blood vessels through paracrine and autocrine patterns. The expression of flk-l was highly associated with the growth, infiltration and metastases of laryngeal carcinoma, which might be an important prognosticindicator for laryngeal carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 1998年第4期260-263,共4页 Cancer Research on Prevention and Treatment
关键词 喉肿瘤 上皮癌变 肿瘤转移 VEGF flk-l laryngeal carcinorna VEGF blood vessel
  • 相关文献

同被引文献48

  • 1王彦君,孔维佳,熊新高,张松,孙大为.Survivin和VEGF蛋白在喉癌组织中的表达及其相关性研究[J].临床耳鼻咽喉科杂志,2005,19(18):838-841. 被引量:10
  • 2陈广理,丁娟,罗凌惠,刘英鹏,鄢开胜,陈沛,宋鹏,付勇,龚树生.血管内皮生长因子及受体在喉癌细胞Hep-2中的表达及意义[J].临床耳鼻咽喉科杂志,2005,19(18):842-844. 被引量:2
  • 3孙大为,王彦君,刘海兵,孔维佳,刘邦华.Ki67和VEGF与喉鳞状细胞癌预后关系的探讨[J].临床耳鼻咽喉科杂志,2006,20(6):246-248. 被引量:3
  • 4郑海洲,林山,汪审清,戴利波.喉鳞状细胞癌血管生成和凋亡的表达及其相关性研究[J].临床耳鼻咽喉科杂志,2006,20(23):1082-1084. 被引量:1
  • 5邓志宏 黄维国 等.血管内皮生长因子(VEGF)在喉粘膜上皮良笥及恶性病变中的表达及其定量研究[J].第四军医大学学报,1997,18(6):385-385.
  • 6Seto T, Higashiyama M, Funai H, et al. Prognostic value of expression of vascular endothelial growth factor and its fh-I and KDR receptors in stage I non-small-cell lung cancer. Lung Cancer, 2006, 53: 91-96.
  • 7Pyaskovskaya ON, Dasyukevich OI, Kolesnik DL, et al. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance. Exp Oncol, 2007, 29: 197-202.
  • 8Inan S, Vatansever S, Celik-Ozenci C, et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. Histol Histopathol, 2006, 21: 1055-1064.
  • 9Mineta H, Miura K, Ogino T, et al. Prognostic vascular endothelial growth factor(VEGF) in head and neck squamous cell carcinomas. Br J Cancer, 2000, 83: 775-781.
  • 10Fukuiwa T, Takebayashi Y, Akiba S, et al. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer, 1999, 85: 960-960.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部